Interaction between von Willebrand factor (VWF) and platelet GP Ib-IX-V is required for hemostasis, in part because intracellular signals from VWF/GP Ib-IX-V activate the ligand-binding function of integrin αIIbβ3. Since they also induce tyrosine phosphorylation of the ADAP adapter, we investigated ADAP's role in GP Ib-IX-V signal transduction. Fibrinogen or ligand-mimetic POW-2 Fab binding to αIIbβ3 was stimulated by adhesion of ADAP +/+ murine platelets to dimeric VWF A1A2, but was significantly reduced in ADAP -/-platelets (P < 0.01). αIIbβ3 activation by ADP or a Par4 thrombin receptor agonist was also decreased in ADAP -/-platelets. ADAP stabilized the expression of another adapter, SKAP-HOM, via interaction with latter's SH3 domain. However, no abnormalities in αIIbβ3 activation were observed in SKAP-HOM -/-platelets, which express normal ADAP levels, further implicating ADAP as a modulator of αIIbβ3 function. Under shear flow conditions over a combined surface of VWF A1A2 and fibronectin to test interactions involving GP Ib-IX-V and αIIbβ3, respectively, ADAP -/-platelets displayed reduced αIIbβ3-dependent stable adhesion. Furthermore, ADAP -/-mice demonstrated increased re-bleeding from tail wounds. These studies establish ADAP as a component of inside-out signaling pathways that couple GP Ib-IX-V and other platelet agonist receptors to αIIbβ3 activation.
INTRODUCTION
Binding of von Willebrand factor (VWF) to GP Ib-IX-V is important for the initial capture of platelets to the extracellular matrix of injured blood vessels at high shear rates [1] [2] [3] . GP Ib-IX-V is a complex of four transmembrane polypeptides [4] [5] [6] . While the cytoplasmic tail of each subunit lacks catalytic function, each may interact directly or indirectly with proteins that can transmit intracellular signals. For example, the cytoplasmic tail of GP Ibα can interact directly with filamin, GP Ibα and Ibβ with 14-3-3-ζ, and GP Ibβ and GPV with calmodulin [7] [8] [9] [10] . GP Ib-IX-V can be co-immunoprecipitated from platelets with signaling molecules, including Src family kinases, 11 PI 3-kinase 12 and SHIP-2 13 . Furthermore, VWFdependent platelet activation may require localization of GP Ib-IX-V to lipid rafts, membrane structures implicated in cellular signaling 14 . In a recent study, we demonstrated that the interaction of GP Ib-IX-V with the dimeric A1 domain of VWF is sufficient to trigger a sequence of reactions in platelets that leads to activation of αIIbβ3 (inside-out signaling), even when co-stimulatory inputs from other agonist receptors are blocked 15 . These reactions include activation of Src family kinases, intracellular Ca
2+
oscillations and the actions of phosphatidyl inositol 3-kinase and protein kinase C. An unanticipated finding was the tyrosine phosphorylation of ADAP, a Src substrate not previously recognized as a potential effector in GP Ib-IX-V signaling.
ADAP ("adhesion and degranulation promoting adapter protein"; previously called Fyb or SLAP-130) is a variably-spliced 120 or 130 kDa protein expressed in T cells and other hematopoietic cells [16] [17] [18] .
Notable domains or motifs in ADAP include: two potential nuclear localization sequences 16 ; polyproline-rich regions in the amino terminal half of the molecule that can interact with the SH3 domains of SKAP55 19 and SKAP-HOM 20, 21 ; and several tyrosines, including Y595 and Y651, which when phosphorylated enable binding to the SH2 domains of SLP-76 or Fyn in T cells 17, 18, 22 . ADAP can potentially modulate cytoskeletal interactions through an FP4 motif that recognizes the EVH1 domain of VASP 23 and a polyproline-rich region that recognizes the SH3 domain of mammalian actin binding protein 1 (mAbp1) 24 . Furthermore, ADAP can co-immunoprecipitate with WASP and Arp 2/3, known regulators of actin polymerization 23, 25 . Thus, ADAP is a candidate linker between cell activation events at the plasma membrane and intracellular events that effect changes in actin polymerization, dynamics and organization.
Studies in ADAP knockout mice or ADAP-deficient T cells have indicated a necessary role for ADAP in the regulation of T cell proliferation and IL-2 production 26 , and the promotion of cell adhesion through clustering and valency modulation of β1 and β2 integrins 27-29 30-32 . However, no information exists as to whether ADAP is necessary for integrin affinity modulation in general or for αIIbβ3 function in platelets. Given the aforementioned tyrosine phosphorylation of ADAP in response to engagement of GP Ib-IX-V 15 , we investigated here whether this adapter is required for GP Ib-IX-V- 
METHODS

Reagents and antibodies
Preparation of dimeric, murine A1A2 VWF (dmA1A2 VWF) was similar to that of human dA1 VWF 33 except that it encompassed residues 445-909 of murine VWF. POW-2, an antibody Fab fragment to murine activated αIIbβ3 has been described [34] [35] [36] . Monoclonal antibody 1B5 against murine αIIbβ3 was from Dr. Barry Coller (Rockefeller University, New York, NY) 37 ; polyclonal antibodies developed against the amino-terminus of murine ADAP, and SKAP-HOM have been described 17, 20, 38, 39 ; monoclonal antibodies against murine CD62P (P-selectin), and anti CD41(αIIb) were from BD Biosciences (San Diego, CA), and a monoclonal antibody against murine GPIbα was from Emfret Analytics (Eibelstadt, Germany). Fibronectin was from Emd Biosciences (San Diego, CA), and fibrinogen from Enzyme Research Laboratories (South Bend, IN). QiaAMP DNA Mini Kit, plasmid vectors pcDNA 3.1 and pIRESeEGFP, and Lipofectamine were from Invitrogen Corporation (Carlsbad, CA). Convulxin was from Alexis Biochemicals (Lausen Switzerland). PPACK was from Haematologic Technologies (Essex Junction, VT). SuperSignal WestPico reagent was from Pierce Chemicals (Rockford, IL). All other reagents were from Sigma Chemical Co. (St. Louis, MO).
Mouse strains and bleeding times
ADAP
-/-and SKAP-HOM -/-mice have been described 28, 40 . ADAP +/+ and SKAP-HOM +/+ mice represent littermate controls. Bleeding time assays were performed by placing the tails of mice in a plexiglass restraining device, pre-warming the tails to 37°C in normal saline, and cutting transversely 0.5 cm from the tip. After immediate re-immersion in the saline solution, the time to arrest of bleeding was noted. Tail bleeding was further monitored for at least an additional 60 seconds to determine if re-bleeding occurred. Statistical analyses for bleeding times and re-bleeding times were performed using Student's ttest and the Χ 2 test, respectively.
Platelet preparation
Mouse blood was obtained by cardiac puncture and diluted with an equal volume of modified Tyrode's buffer (140 mM NaCl, 2.7 mM KCl, 0.4 mM NaH2PO4.H2O, 10 mM NaHCO3, 5 mM dextrose, pH 6.5) containing acid-citrate dextrose anticoagulant and 1.5 U/ml apyrase. After centrifugation for 4 min To determine the surface expression of αIIbβ3 and GP Ibα, platelets were incubated with an antibody against murine anti-CD41 (αIIb) or against murine GP Ibα in Tyrodes buffer (137 mM NaCl, 12 mM NaHCO3, 26 mM KCl, 5.5 mM glucose, 0.1 % BSA, 5.0 mM Hepes, 0.5 mM CaCl2, 1 mM MgCl2, pH 7.4), for 30 minutes. Platelet suspensions were diluted with buffer and the amount of antibody bound to platelets was determined by flow cytometry. CD62P (P-selectin) surface expression, reporting on alphagranule secretion, was determined by flow cytometric analysis of binding of an antibody against murine CD62P in platelets that were resting or stimulated with 250 µM Par4 receptor-activating peptide (AYPGKF). Statistical analyses were performed using Student's t-test.
Measurements of αIIbβ3 affinity state
Binding of FITC-fibrinogen or POW-2 Fab 41 to mouse platelets adherent to dmA1A2 VWF was evaluated by deconvolution microscopy. Glass coverslips were coated with 15 µg/ml of dmA1A2 VWF for 1 hour at room temperature, and blocked with 1% denatured bovine serum albumin. Platelets were added to the coverslips for 40 min at 37°C, routinely in the presence of FITC-fibrinogen or POW-2 Fab, 2 U/ml apyrase, 10 µM indomethacin and a phycoerythin-conjugated, non-inhibitory antibody to β3, the latter to facilitate discrimination of the cell outline. Non-specific fibrinogen or POW-2 Fab binding was assessed in the presence of 5 mM EDTA. Adherent platelets were washed gently with phosphatebuffered saline, fixed with 3.7 % formaldehyde, and stained with Alexa-488-conjugated anti-murine H + L chain-specific IgG (for POW-2 Fab). Images were captured with a Deltavision deconvolution microscope (Applied Precision Inc., Issaquah, WA) using a Photometrics Sony Coolsnap HQ chargedcoupled device camera system attached to an inverted, wide-field fluorescence microscope (Nikon TE-200) equipped with a 100x, Nikon (NA 1.4) oil immersion objective. Identical settings were used for slides from all experimental conditions. Platelet fluorescence intensity range was standardized in deconvolution micrographs using the Softworks Analysis Program (Applied Precision Inc., Issaquah, WA). Single cell analysis was performed by calculating fluorescence intensities for FITC-fibrinogen bound to each cell using Image-Pro Plus Software (Media Cybernetics, Silver Spring, MD). The mean for each group was determined from data derived from 50-300 cells per experimental condition for both ADAP +/+ and ADAP -/-platelets. Results are expressed as the percentage of average ADAP +/+ fluorescence ± standard error of the mean (SEM). To determine the role of ADAP in αIIbβ3 activation
For personal use only. on September 24, 2017. by guest www.bloodjournal.org From through agonists other than GP Ib-IX-V, platelets from ADAP +/+ and ADAP -/-mice were stimulated with varying concentrations of ADP, Par4-activating peptide 42 or convulxin in the presence of FITCfibrinogen, and bound FITC-fibrinogen was assessed by flow cytometry at equilibrium binding conditions. Platelet aggregation was measured as previously described 45 . Statistical analyses were performed using Student's t-test.
Platelet adhesion under flow conditions
Whole blood was drawn from the retro-orbital plexus and anticoagulated with 40 µg/ml PPACK. Platelet number was adjusted in blood from ADAP +/+ mice to correspond to the reduced counts in ADAP -/-mice, by centrifuging for 8 minutes at 750 x g, and carefully depleting platelets from the buffy coat, thus maintaining hematocrit. Remaining cells and plasma were re-blended very gently. Glass coverslips were coated with either 20 µg/ml dmA1A2 VWF, 25 µg/ml fibronectin or a combination of the two for 45 minutes at room temperature, rinsed with buffer containing 20 mM Hepes and 150 mM NaCl, and mounted in a parallel plate flow chamber maintained at 37 0 C. Platelet dense granules were labeled by addition of 20 µg/ml mepacrine to whole blood to allow platelet visualization with an inverted epifluorescence microscope 1 . Blood was aspirated through the chamber, at a shear rate of 1500
No platelets were in contact with the surface prior to initiation of shear flow. Analog videotaped images of platelets directly captured to the surface from shear flow were subsequently digitized using Adobe Premiere (Adobe Systems, San Jose, CA) and analyzed using Metamorph software (Universal Imaging, West Chester, PA). The number of platelets that remain stationary (displaced by less than one cell diameter) for the specified time period was calculated and expressed as a percentage of the total number of platelets contacting the surface over the period of observation. Data are shown for platelets adherent at 20 seconds, 1 or 2 minutes following initiation of flow. 800-1500 platelets were analyzed for each data point shown. Following flow, platelets were fixed in situ by flowing 3.7% formaldehyde, rinsed, permeabilized and stained with a non-inhibitory, FITC-conjugated antibody against αIIb.
Studies of ADAP and SKAP-HOM in a CHO cell model system A5 CHO cells that stably express αIIbβ3 were a gift from Dr. M. Ginsberg (University of California, San Diego, San Diego, CA) and cultured as described 43 . The following mammalian expression plasmids were used: pEF-BOS/Flag-tagged SKAP-HOM 20 , and pEF/Flag-tagged ADAP 17 . The SKAP-HOM plasmid was used as a PCR template to obtain full-length SKAP-HOM and SKAP-HOM lacking the amino terminal SH3 domain, and PCR products were sub-cloned into pIRES2-EGFP (Invitrogen/BD Biosciences), at 5' Xho1 and 3' Sac-1 restriction sites. Coding sequences were confirmed by automated DNA sequencing. For transfection, subconfluent cells in 100 mm plates were transfected with a maximum of 6 µg of plasmid DNA using Lipofectamine according to manufacturer's instructions (Invitrogen/BD Biosciences). When required, pcDNA 3.1 (Invitrogen) was used to maintain equal quantities of cDNA per transfection. Cells were examined for ADAP and SKAP-HOM expression 48 hours after transfection, a time point verified to produce maximal recombinant protein levels.
RESULTS AND DISCUSSION
ADAP-deficient mice re-bleed from tail wounds
To address the role of ADAP in platelet function, we studied mice deficient in this protein. Tail bleeding times in the mouse can be prolonged if there are coagulation abnormalities or platelet dysfunction, but not mild thrombocytopenia 44 although subtle defects in platelet function may yield only an increase in tail re-bleeding frequency due to thrombus fragility 45 . ADAP -/-mice exhibited bleeding times comparable to their ADAP +/+ littermates ( Figure 1A ), confirming that the mild thrombocytopenia in these mice 28 was not itself sufficient to prolong bleeding. However, whereas only 21.9 % of ADAP +/+ mice showed re-bleeding from tail wounds within one minute of initial arrest, 61.8 % of ADAP -/-mice re-bled (P < 0.01 % in a Χ 2 test) ( Figure 1B ). Plasma from ADAP -/-mice showed normal thrombin and activated partial thromoboplastin times (not shown), suggesting that the higher re-bleeding rate in ADAP -/-mice was likely due to platelet dysfunction.
Characterization of ADAP -/-Platelets
Expression of GP Ib-IX-V and αIIbβ3 was comparable in ADAP +/+ and ADAP -/-platelets as assessed by flow cytometry (Figure 2A and B). The botrocetin-mediated binding of FITC-VWF was also comparable, indicating that GP Ib-IX-V can interact normally with VWF (not shown). ADAP -/-platelets also exhibited normal α-granule secretion in response to Par4-activating peptide, as measured by surface expression of P-selectin. Thus, to the extent that α-granule secretion my contribute to thrombus growth or stability, a defect in this process is not likely to be the primary cause of the increased frequency of tail re-bleeding observed in the ADAP -/-mice.
ADAP is required for normal αIIbβ3 activation
Primary hemostasis is reliant on initial capture of platelets to the vessel wall, platelet activation and recruitment of additional platelets into growing thrombi. GP Ib-IX-V is important from this standpoint, and Bernard Soulier patients, or mice deficient in GP Ibα exhibit severe bleeding defects 46 . GP Ib-IX-V is the only known receptor that can successfully mediate platelet capture across a wide range of physiologically relevant shear stresses 47, 48 . Furthermore, its signaling functions are important for Apyrase and indomethacin were present to prevent co-stimulatory effects of ADP and thromboxane A 2 , respectively 15 . Adhesion of wild-type ADAP +/+ platelets to dmA1A2 VWF induced the binding of FITC-fibrinogen, as evidenced by patches of green fluorescence associated with the platelets ( Figure  3A) . Fibrinogen binding was αIIbβ3-specific because it was prevented by EDTA ( Figure 3B ) and by 1B5, a function-blocking antibody to αIIbβ3 (data not shown). In contrast, there was much less specific FITC-fibrinogen binding to ADAP -/-platelets under the same conditions ( Figure 3D,E) . A quantitative analysis indicated a statistically significant 64 ± 10% decrease in FITC-fibrinogen binding to ADAP To confirm that adhesion to dmA1A2 VWF stimulated an increase in αIIbβ3 affinity, the binding of POW-2, a ligand-mimetic, monovalent anti-αIIbβ3 antibody Fab, was assessed. Compared to ADAP +/+ platelets, there was a 94 ± 5% decrease in POW-2 binding to ADAP -/-platelets ( Figure 3H , P < 0.01).
Taken together, these results indicate that ADAP is involved in the modulation of αIIbβ3 affinity in response to ligation of GP Ib-IX-V by dmA1A2 VWF.
Since GP Ib-IX-V is important for mediating initial platelet surface interactions under shear flow, we tested whether ADAP was required for activation of αIIbβ3 and stable adhesion in platelets captured from shear flow through GP Ib-IX-V. In preliminary experiments, we verified that adhesion and translocation on dmA1A2 VWF were normal in ADAP -/-platelets and therefore any differences observed in stable adhesion would not be attributable to defective VWF/GP Ib-IX-V interactions. Blood was perfused at a wall shear rate of G = 1500 s -1 over a surface of either dmA1A2 VWF, fibronectin, or a combination of the two. Unlike for adhesion to immobilized fibrinogen 1 , αIIbβ3 must be in a high affinity state in order to stably adhere to fibronectin in shear flow 51 . Thus, with a mixed dmA1A2 VWF/fibronectin surface, we expected that initial platelet contacts through the GP Ib-IX-V/VWF A1 domain interaction would be reinforced by contacts through the αIIbβ3/fibronectin interaction only if αIIbβ3 had become activated. Indeed, this was the case for ADAP +/+ platelets, which displayed an increase in the average time that they remained stably adherent to the combined dmA1A2 VWF/fibronectin surface when compared to the single dmA1A2 VWF surface ( Figure 4A ,B) (P < 0.05).
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The function-blocking anti-αIIbβ3 antibody 1B5 reduced stable adhesion to the combined surface to levels observed with dmA1A2 VWF alone (not shown)(P < 0.05), confirming that this response was αIIbβ3-dependent. Almost no platelet adhesion to a surface of fibronectin alone nor soluble thrombi were observed at this shear rate, indicating that platelets that were stably adherent had not simply become pre-activated during preparative procedures. In contrast to ADAP +/+ platelets, stable adhesion of ADAP -/-platelets to the combined surface was impaired (Figure 4 A,B) . While on the dmA1A2 VWF surface, ADAP +/+ and ADAP -/-platelets showed similar levels of adhesion, on the combined surface with the αIIbβ3 ligand, fibronectin, ADAP -/-platelets were less able to adhere stably. Whereas, there was a 27 -43 % decrease in the percentage of ADAP -/-platelets stably adherent for at least 3.5 s ( Figure   4A ), the decrease in the percentage of platelets stably adherent for at least 10 seconds was 50 -85% (P < 0.05) at the time points after initiation of flow shown ( Figure 4B ). It is possible that multimeric VWF may have provided a better substrate than a combined matrix of dmA1A2 VWF and fibronectin since GP Ib-IX-V and αIIbβ3 binding sites are optimally present within the same molecule. However, VWF was not used as a surface because murine GP Ibα does not recognize human VWF directly, and murine VWF was not available. Nevertheless, under conditions of shear flow we were able to distinguish small but significant increases in stable adhesion when the fibronectin αIIbβ3 ligand was presented on the surface along with dmA1A2 VWF. Thus, results are consistent with a role for ADAP in inside-out signaling and activation of αIIbβ3 initiated by platelet adhesion through GP Ib-IX-V. The differences observed in stable adhesion between ADAP +/+ and ADAP -/-platelets may also be due in part to differences in response to generated secondary agonists, stabilization of ligand-receptor contacts, and cytoskeletal reinforcements [52] [53] [54] [55] .
One consequence of αIIbβ3 interaction with ligands such as fibrinogen is outside-in signaling, leading to cytoskeletal rearrangements and the development of filopodial and lamellipodial extensions. In the absence of soluble agonists such as ADP, mouse platelets adherent to fibrinogen exhibit more filopodia and fewer lamellipodia compared to human platelets. Spreading of ADAP +/+ platelets on the combined dmA1A2 VWF/ fibronectin surface under shear flow was limited mostly to filopodial extension ( Figure  5A ), a response that was reduced in ADAP -/-platelets ( Figure 5B ). Thus, while 51 ± 7 % of ADAP +/+ cells showed one or more filopodia on dmA1A2 VWF/fibronectin, only 27 ± 3 % of ADAP -/-platelets showed filopodia (Figure 5 C, P < 0.05). No such difference between wild-type and knockout platelets was noted on dmA1A2 VWF alone (25 and 24 % respectively) ( Figure 5B, C) . Additionally, the filopodia of ADAP +/+ platelets on the combined surface tended to be longer than the few produced on the single surface or the ones exhibited by ADAP -/-platelets on either surface ( Figure 5A, B) .
Altogether, these results indicate that ADAP +/+ platelets undergo GP Ib-IX-V-dependent activation of 18-50% decrease in the maximum aggregation at 2 min, and after 2-5 µM ADP, the ADAP -/-platelets disaggregated while the wild-type platelets did not (not shown). As ADAP deficiency impairs αIIbβ3 activation by several agonists, ADAP may transduce signals through modulators, such as talin, or stabilize signaling complexes that converge on the integrin cytoplasmic tails to modulate affinity 36, 56 . It has been suggested that talin interaction with integrins may be regulated by phosphorylation, binding of PIP2 or calpain-mediated proteolysis 57,58 59,60 . ADAP could participate in talin regulation by increasing intracellular calcium levels and activating protein kinase C 61 or calpain 59 . Alternatively, ADAP might regulate access of PIP2 to talin by interacting with PIP2 through the ADAP extended helical SH3 domain 62 . Finally, the small GTPase, Rap1 has been implicated in promoting ligand binding to integrins 63 . Perhaps ADAP influences the localization of Rap1b effectors to talin. Further studies are required to assess these possibilities.
The ADAP-binding partner, SKAP-HOM, is not required for αIIbβ3 activation ADAP and SKAP-HOM, its binding partner, have been detected in macromolecular complexes upon platelet activation through GPVI 64 . In the process of evaluating ADAP-binding proteins, we discovered that SKAP-HOM protein levels were undetectable in ADAP -/-mouse platelets ( Figure 7A ). This is similar to observations that ADAP may be required for regulating levels of SKAP55 in a Jurkat T cell line 65 , and SKAP-HOM levels in lymphocytes 66 . In order to investigate whether ADAP can regulate SKAP-HOM independently of other proteins with which it may be associated in hematopoietic cells, we transfected CHO cells with expression vectors for each of these proteins. Very little SKAP-HOM protein was detected when it was transfected without ADAP ( Figure 7B ). However, SKAP-HOM was readily detected when co-transfected with ADAP. This was not observed with a SKAP-HOM mutant lacking the SH3 domain ( Figure 7B ). Thus, ADAP stabilizes SKAP-HOM protein levels in a manner dependent on the SKAP-HOM SH3 domain.
SKAP55, a protein homologous to SKAP-HOM is not expressed in platelets 64 . However, it associates with ADAP in T cells 20 , and has been implicated in integrin-mediated T-cell adhesion 27, 28 . Therefore, the absence of SKAP-HOM in ADAP -/-platelets raised the possibility that it and not ADAP is required for αIIbβ3 activation. To address this possibility, SKAP-HOM -/-mice were studied 40 . These mice exhibited platelet numbers and levels of platelet ADAP similar to wild-type littermates. However, unlike the results with ADAP -/-platelets, SKAP-HOM -/-platelets bound fibrinogen normally after adhesion to dmA1A2 VWF or stimulation with PMA ( Figure 7C ). In addition, SKAP-HOM -/-platelets bound FITCfibrinogen normally in response to 10 µM ADP or 250 µM Par4 receptor-activating peptide (not shown). Thus, ADAP and not SKAP-HOM is required for signaling through GP Ib IX-V and other agonists to αIIbβ3.
Taken together, these studies establish that ADAP is involved in: 1) normal GP Ib-IX-V induced signaling to αIIbβ3, both under static and shear flow conditions; 2) αIIbβ3 activation downstream of agonists acting through G-protein-coupled receptors; 3) regulation of platelet expression of SKAP-HOM; and 4) normal platelet function in vivo as assessed by re-bleeding from tail wounds. Thus, ADAP deficiency has several consequences for platelet function through the promotion of integrin activation and stable adhesion under shear flow. This discovery raises new questions. Does the increased frequency of re-bleeding from tail wounds in ADAP -/-mice mean that defects in GP Ib-IX-V signaling can lead to unstable thrombi in vivo? If so, would it be possible to selectively block this signaling pathway to achieve an anti-thrombotic effect with minimal disruption of hemostasis? Does ADAP influence platelet function through interactions with known modulators of αIIbβ3 affinity, such as talin or Rap1b, or does it regulate αIIbβ3 affinity by a novel mechanism? The answers to these questions will illuminate how one major class of platelet adhesion receptor communicates with another. Figure 6A , was used as a positive control, and blots were re-probed with a β-actin antibody to monitor gel loading. C. Platelets from wild-type or SKAP-HOM knockout mice were allowed to adhere to dmA1A2 VWF as described in Figure 2 , and integrin activation was assessed by FITC-fibrinogen binding in the presence or absence of a cocktail of inhibitors, or PMA. Results in A and B are representative of at least three experiments, with similar results. Results in C are for ADAP -/-platelets (white bars), depicted as a percentage of soluble ligand that is specifically bound by ADAP +/+ platelets (black bars) ± SEM., and are a summary of three separate experiments.
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